Prescribing antidepressants for depression: Time to be dimensional and inclusive

British Journal of General Practice

Volumn 61, Issue 582, 2011, Pages 50-52

  Anderson, Ian M ^a   Haddad, Peter M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Antidepressants; Depression; Placebo; Psychological treatment; Randomised controlled trials

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROTRANSMITTER; PLACEBO; SEROTONIN;

BEHAVIOR THERAPY; BRAIN; BRAIN FUNCTION; COGNITIVE THERAPY; DEPRESSION; DRUG EFFICACY; DYSTHYMIA; ELECTROENCEPHALOGRAM; EMOTION; HUMAN; NOTE; PRESCRIPTION; PSYCHOLOGICAL ASPECT; ARTICLE; METHODOLOGY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARD; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 79957466078     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp11X548992     Document Type: Note

References (12)

1. Middleton H, Moncrieff J. 'They won't do any harm and might do some good': time to think again on the use of antidepressants? Br J Gen Pract 2011; 61: 47-49.
2. National Institute for Health and Clinical Excellence. Depression: the treatment and management of depression in adults (update). Clinical guideline 90. London: National Institute for Health and Clinical Excellence, 2009. http://guidance.nice.org.uk/CG90/Guidance/pdf/English (accessed 4 Nov 2010).
3. Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156(5): 675-682. (Pubitemid 29220063)
4. Elliott R, Zahn R, Deakin JF, Anderson IM. Affective cognition and its disruption in mood disorders. Neuropsychopharmacology 2010; [epub ahead of print].
5. Smith KA, Morris JS, Friston KJ, et al. Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. Br J Psychiatry 1999; 174: 525-529. (Pubitemid 29278687)
6. Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008; 5: e45. doi:10.1371/journal.pmed.0050045.
7. Fountoulakis KN, Moller HJ. Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data. Int J Neuropsychopharmacol 2010; Aug 27: 1-8. [Epub ahead of print].
8. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010; 303(1): 47-53.
9. Parker G, Anderson IM, Haddad P. Clinical trials of antidepressant medications are producing meaningless results. Br J Psychiatry 2003; 183: 102-104. (Pubitemid 36963134)
10. Kendrick T, Chatwin J, Dowrick C, et al. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study. Health Technol Assess 2009; 13(22): iii-xi, 1-159.
11. Okiishi JC, Lambert MJ, Eggett D, et al. An analysis of therapist treatment effects: toward providing feedback to individual therapists on their clients' psychotherapy outcome. J Clin Psychol 2006; 62(9):1157-1172. (Pubitemid 44320295)
12. Lynch D, Laws KR, McKenna PJ. Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials. Psychol Med 2010; 40(1): 9-24.